Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation
作者:Hongtao Du、Xinyu Jiang、Meng Ma、Huili Xu、Shuang Liu、Fang Ma
DOI:10.1016/j.bmcl.2020.127659
日期:2020.12
A novel series of deoxyvasicinone-tetrahydro-beta-carboline hybrids were synthesized and evaluated as acetylcholinesterase (AChE) and β-amyloid peptide (Aβ) aggregation inhibitors for the treatment of Alzheimer’s disease. The results revealed that the derivatives had multifunctional profiles, including AChE inhibition, Aβ1-42 aggregation inhibition, and neuroprotective properties. Inspiringly, hybrids
一种新型系列deoxyvasicinone四氢的测试咔杂交的合成和评价为乙酰胆碱酯酶和β淀粉样肽(A β)聚集抑制剂为阿耳茨海默氏病的治疗。结果表明,该衍生物具有多功能个人资料,包括乙酰胆碱酯酶抑制,A β 1-42凝集抑制和神经保护性质。鼓舞地,杂种8B和8D显示针对优异的抑制活性ħ乙酰胆碱酯酶(IC 50 分别= 0.93和1.08纳米,)和A β 1-42自聚集(IC 50 分别为19.71和2.05μM)。另外,图8b和图8d显示出低细胞毒性和良好的神经保护活性对甲β 1-42在SH-SY5Y细胞诱导的损伤。